A newly identified disorder, MINA syndrome, results from a mutation in the NAMPT protein that deprives motor neurons of ...
UNC School of Medicine researchers have led an international clinical trial of patients with generalized myasthenia gravis, finding the therapy is safe and effective across all subtypes.